ONOMA — demonstration

What a pharmaceutical brand-name review covers, shown on invented candidates.

Try it — invented names, invented register Demo — synthetic data

Type an indication and this page will offer sample names from a small fabricated set, and tell you whether each one clashes with a fabricated list of names already taken. Every name on both sides is invented for this demonstration. Nothing here touches the governed register, no account is involved, and nothing is sent anywhere — the whole thing runs in this page.

Try:

Candidate shortlist (synthetic)

Candidate What the review would examine Assessment
Velmoryn Stem separation against the register; nearest-neighbour look-alike and sound-alike checks. Available after sign-in
Cardexa Whether a crowded therapeutic prefix creates confusion with existing cardiovascular names. Available after sign-in
Ostivera Vowel rhythm and syllable structure; overlap with an established naming family. Available after sign-in
Nuvexil Whether a suffix implies a therapeutic class the product does not belong to. Available after sign-in
Betrilume Length and opening consonant; how the name survives handwriting and verbal orders. Available after sign-in
Zaltrion Initial-letter rarity and overall silhouette against the register. Available after sign-in

Assessments are withheld here on purpose. This page shows what a review examines, never how any of it is weighed — no weights, no thresholds and no candidate results are published, and the page carries no script that could produce one.

What a review examines

These are the dimensions a naming dossier addresses. Their relative weight, the bands applied to them and any resulting figure are part of the product and are not published.